U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Allergan plc (AGN)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
204.65+1.99 (+0.98%)
At close: 4:00PM EDT

204.50 -0.15 (-0.07%)
After hours: 7:57PM EDT

People also watch
BIIBCELGVRXGILDREGN
Full screen
Previous Close202.66
Open202.50
Bid0.00 x 0
Ask0.00 x 0
Day's Range201.42 - 209.25
52 Week Range184.50 - 256.80
Volume3,903,828
Avg. Volume2,152,845
Market Cap68.42B
Beta1.24
PE Ratio (TTM)6.24
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.80 (1.30%)
Ex-Dividend Date2017-08-16
1y Target EstN/A
Trade prices are not sourced from all markets
  • Why Allergan's Hepatitis Drug Likely Won't Get FDA Approval
    Investor's Business Daily4 hours ago

    Why Allergan's Hepatitis Drug Likely Won't Get FDA Approval

    Allergan is advancing a nonalcoholic steatohepatitis drug into Phase 3 testing that likely won't get FDA approval.

  • Native American tribe moves to dismiss Allergan patent case
    Reuters5 hours ago

    Native American tribe moves to dismiss Allergan patent case

    In a filing to the U.S. Patent Trial and Appeal Board, the Saint Regis Mohawk Tribe asked that Mylan's case seeking to invalidate Allergan's patents on dry-eye medicine Restasis be thrown out on the grounds that the board has no jurisdiction over the tribe. The move was expected after Allergan announced on Sept. 8 that it had transferred Restasis patents to the tribe in order to protect them from administrative challenges.

  • Allergan Needs to Learn to Let Go
    Bloomberg8 hours ago

    Allergan Needs to Learn to Let Go

    Pressing ahead after mixed data is usually a recipe for failure.